Introducing CoverScan

The product of our latest research is CoverScan, a noninvasive imaging tool to assess the health of six organs using a single scan. We developed this product over a two-year journey working alongside our long COVID study community participants.

This work has enabled us to assess multi-organ impairment in patients affected by long COVID and other conditions, whilst also investigating the inequalities in access and provision of high-quality long COVID care.

Perspectum’s Prof. Sir Mike Brady and Dr. Rajarshi Banerjee are team members of the largest long COVID clinical study to-date — STIMULATE-ICP — led by University College London Hospitals NHS Trust and University College London, together with researchers, health professionals, patients, and industry partners from over 30 organizations.